Brokerages Set Gevo, Inc. (NASDAQ:GEVO) Target Price at $6.42

Shares of Gevo, Inc. (NASDAQ:GEVO) have earned an average recommendation of “Hold” from the five analysts that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $6.4167.

Several analysts have recently issued reports on the company. Wall Street Zen lowered Gevo from a “hold” rating to a “sell” rating in a report on Saturday, March 7th. Northland Securities reaffirmed an “outperform” rating and issued a $3.00 price target on shares of Gevo in a research note on Wednesday, December 31st. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Gevo in a research report on Thursday, January 22nd.

Insider Activity at Gevo

In other Gevo news, insider Lindsay Clinton Fitzgerald sold 20,000 shares of the company’s stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $2.51, for a total transaction of $50,200.00. Following the completion of the sale, the insider directly owned 212,199 shares in the company, valued at $532,619.49. This represents a 8.61% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gary W. Mize sold 107,100 shares of the firm’s stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $2.33, for a total value of $249,543.00. Following the completion of the sale, the director directly owned 281,226 shares in the company, valued at approximately $655,256.58. This represents a 27.58% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 142,650 shares of company stock worth $332,909 in the last quarter. 4.00% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Gevo

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Key Client Fiduciary Advisors LLC bought a new stake in shares of Gevo during the fourth quarter worth $25,000. Berger Financial Group Inc acquired a new stake in shares of Gevo during the 4th quarter valued at $26,000. Franklin Resources Inc. bought a new stake in Gevo during the 4th quarter worth $28,000. Mackenzie Financial Corp bought a new stake in Gevo during the 3rd quarter worth $29,000. Finally, Cibc World Markets Corp acquired a new position in Gevo in the 4th quarter worth about $31,000. 35.17% of the stock is owned by institutional investors.

Gevo Price Performance

Gevo stock opened at $2.38 on Wednesday. The company has a market capitalization of $577.91 million, a price-to-earnings ratio of -18.31 and a beta of 1.51. The company has a current ratio of 1.82, a quick ratio of 1.58 and a debt-to-equity ratio of 0.35. Gevo has a 12 month low of $0.92 and a 12 month high of $2.95. The stock’s 50 day moving average is $1.98 and its 200-day moving average is $2.06.

Gevo (NASDAQ:GEVO) last released its quarterly earnings results on Thursday, March 5th. The energy company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.01. The business had revenue of $45.35 million during the quarter, compared to the consensus estimate of $43.52 million. Gevo had a negative return on equity of 7.20% and a negative net margin of 21.07%. Equities research analysts expect that Gevo will post -0.42 EPS for the current year.

About Gevo

Gevo, Inc (NASDAQ: GEVO) is a renewable chemicals and biofuels company that develops and produces low-carbon alternatives to petroleum-based products. The company’s core technology platform converts fermentable sugars into isobutanol, which can be further processed into sustainable aviation fuel (SAF), renewable gasoline, diesel, and jet fuel. Gevo’s integrated biorefinery model combines fermentation, recovery, and downstream processing to deliver scalable, drop-in replacements for conventional fossil-derived hydrocarbons.

Gevo’s primary products include isobutanol, a four-carbon alcohol used as a building block for various fuels and chemicals, and hydrocarbon fuels that meet ASTM specifications for aviation and road transport.